Keratinocyte Growth Factor Ameliorates Dextran Sodium Sulfate Colitis in Mice.
EGGER, BERNHARD MD; PROCACCINO, FRANK MD; SAROSI, ILDIKO MD, PhD; TOLMOS, JORGE MD; BUCHLER, MARKUS W. MD; EYSSELEIN, VIKTOR E. MD
[Miscellaneous Article] Digestive Diseases & Sciences. 44(4):836-844, April 1999.

(Format: HTML)

Keratinocyte growth factor (KGF) is emerging as an important mediator of mucosal defense and repair in the colon. The aim of the present study was to evaluate and further characterize the effects of exogenous KGF administration utilizing the dextran sodium sulfate (DSS) model of colitis in mice. Colitis was induced via oral administration of DSS (5 g/100 ml) to Balb/c mice for eight days. Intraperitoneal administration of KGF (5 mg/kg, once daily) or vehicle (VEH) was initiated 1 hr prior to the induction of the colitis (N = 10, each group). Mucosal injury of the entire colon was histologically assessed and graded. An approximately fourfold reduction in the crypt damage score was noted in the KGF group when compared to controls (VEH) (2.8 /- 1.03 and 11.4 /- 0.78, respectively). The significant reduction of mucosal injury in KGF treated mice confirms that KGF is a key mediator maintaining the integrity of the colonic mucosa.

(C) Plenum Publishing Corporation 1999. All Rights Reserved.